Suppr超能文献

相似文献

2
Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
J Infect Chemother. 2018 Apr;24(4):315-318. doi: 10.1016/j.jiac.2017.10.022. Epub 2017 Dec 7.
6
Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin.
Diagn Microbiol Infect Dis. 1998 Mar;30(3):197-203. doi: 10.1016/s0732-8893(97)00241-1.
7
Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.
Diagn Microbiol Infect Dis. 2004 Jul;49(3):179-82. doi: 10.1016/j.diagmicrobio.2004.04.003.
8
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
J Microbiol Immunol Infect. 2018 Oct;51(5):636-643. doi: 10.1016/j.jmii.2017.05.001. Epub 2017 Jun 28.
9
Minimum inhibitory concentrations of azithromycin in clinical isolates of complex in Japan.
Microbiol Spectr. 2024 Jun 4;12(6):e0021824. doi: 10.1128/spectrum.00218-24. Epub 2024 Apr 30.
10
Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
J Glob Antimicrob Resist. 2022 Dec;31:90-97. doi: 10.1016/j.jgar.2022.05.027. Epub 2022 Jun 2.

引用本文的文献

1
Treatment outcomes and relapse in patients with complex pulmonary disease.
Microbiol Spectr. 2023 Sep 27;11(5):e0164023. doi: 10.1128/spectrum.01640-23.
2
Variability of Complex Isolates Drug Susceptibility Testing by Broth Microdilution.
Antibiotics (Basel). 2022 Dec 4;11(12):1756. doi: 10.3390/antibiotics11121756.
3
Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00755-19. Print 2019 Sep.
4
Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
PLoS One. 2018 Sep 17;13(9):e0203108. doi: 10.1371/journal.pone.0203108. eCollection 2018.
5
MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease.
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.00491-18. Print 2018 Oct.
7
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.
Drug Des Devel Ther. 2016 Apr 1;10:1307-22. doi: 10.2147/DDDT.S101486. eCollection 2016.
8
Highlight on advances in nontuberculous mycobacterial disease in North America.
Biomed Res Int. 2014;2014:919474. doi: 10.1155/2014/919474. Epub 2014 Sep 11.

本文引用的文献

1
Diagnosis and treatment of lung infection with nontuberculous mycobacteria.
Curr Opin Pulm Med. 2009 May;15(3):201-8. doi: 10.1097/MCP.0b013e3283292679.
2
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
3
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Chest. 2006 Oct;130(4):1234-41. doi: 10.1378/chest.130.4.1234.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验